(Stroke. 2000;31:1735.)
© 2000 American Heart Association, Inc.
Original Contributions |
Contribution of Microglia/Macrophages to Expansion of Infarction and Response of Oligodendrocytes After Focal Cerebral Ischemia in Rats
From the Department of Internal Medicine and Therapeutics, Division of Strokology (T.M., K. Kitagawa, T.O., K. Kuwabara, Y.Y., M.H., M.M.), and Department of Neurology (T.Y., M.M.), Osaka University Graduate School of Medicine (Japan).
Background and Purpose—The purpose of this study was (1) to examine the contribution of microglia and macrophages with their interleukin-1ß production and (2) to assess the vulnerability and response of oligodendrocytes in cerebral infarction.
Methods—Male Wistar rats were subjected to permanent occlusion of the left middle cerebral artery. Expansion of ischemic infarction and response of oligodendrocytes were investigated together with accumulation of inflammatory cells, production of interleukin-1ß, and disruption of the blood-brain barrier. Apoptotic cell death was inferred from fragmented DNA and the expression of proapoptotic Bax protein.
Results—During expansion of infarction, amoeboid microglia and extravasation of serum albumin were observed not only in the infarcted area but also in the adjacent surviving area, whereas macrophages accumulated along the boundary and granulocytes migrated into the center of the infarction. Both amoeboid microglia and macrophages produced interleukin-1ß, an inflammatory cytokine, during an early ischemic period. Furthermore, macrophages within the infarcted tissue expressed Bax protein and subsequently showed fragmented nuclear DNA. Oligodendrocytes were detected in the infarcted area even after 24 hours following middle cerebral artery occlusion, but they subsequently developed fragmented DNA. A week after onset of ischemia, oligodendrocytes were found to be accumulated in the intact area bordered with the infarct together with reactive astrocytes.
Conclusions—-Our results suggest the importance of amoeboid microglia, macrophages, and their interleukin-1ß production in gradual expansion of cerebral infarction. Resident oligodendrocytes may be resistant to ischemic insults, and oligodendrocytes accumulated at the border of the infarction may participate in tissue repair after cerebral infarction.
Editorial Comment
Guest Editors Department of Molecular and Experimental Medicine The Scripps Research Institute La Jolla, California
This article has been cited by other articles:
 |
|
 |
|
  S. Lee, J.-Y. Park, W.-H. Lee, H. Kim, H.-C. Park, K. Mori, and K. Suk Lipocalin-2 Is an Autocrine Mediator of Reactive Astrocytosis J. Neurosci., January 7, 2009; 29(1): 234 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Milner, S. J. Crocker, S. Hung, X. Wang, R. F. Frausto, and G. J. del Zoppo Fibronectin- and Vitronectin-Induced Microglial Activation and Matrix Metalloproteinase-9 Expression Is Mediated by Integrins {alpha}5beta1 and {alpha}vbeta5 J. Immunol., June 15, 2007; 178(12): 8158 - 8167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lu, C.-L. Cho, C.-L. Liang, S.-D. Chen, P.-C. Liliang, S.-Y. Wang, and H.-J. Chen Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 934 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. del Zoppo, R. Milner, T. Mabuchi, S. Hung, X. Wang, G. I. Berg, and J. A. Koziol Microglial Activation and Matrix Protease Generation During Focal Cerebral Ischemia Stroke, February 1, 2007; 38(2): 646 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J.S. Price, D. Wang, D. K. Menon, J. V. Guadagno, M. Cleij, T. Fryer, F. Aigbirhio, J.-C. Baron, and E. A. Warburton Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke Stroke, July 1, 2006; 37(7): 1749 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Rosenzweig, N. S. Lessov, D. C. Henshall, M. Minami, R. P. Simon, and M. P. Stenzel-Poore Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice Stroke, November 1, 2004; 35(11): 2576 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tanaka, K. Kitagawa, S. Sugiura, E. Matsuoka-Omura, T. Sasaki, Y. Yagita, and M. Hori Infiltrating Macrophages as In Vivo Targets for Intravenous Gene Delivery in Cerebral Infarction Stroke, August 1, 2004; 35(8): 1968 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsunemi, S. Takai, M. Nishimoto, D. Jin, M. Sakaguchi, M. Muramatsu, A. Yuda, S. Sasaki, and M. Miyazaki A Specific Chymase Inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), Suppresses Development of Abdominal Aortic Aneurysm in Hamsters J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 879 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Marcheselli, S. Hong, W. J. Lukiw, X. H. Tian, K. Gronert, A. Musto, M. Hardy, J. M. Gimenez, N. Chiang, C. N. Serhan, et al. Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression J. Biol. Chem., October 31, 2003; 278(44): 43807 - 43817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, J. Culman, A. Blume, S. Brecht, and P. Gohlke Chronic Treatment With a Low Dose of Lithium Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death Stroke, May 1, 2003; 34(5): 1287 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Marks, H. V.O. Carswell, E. E. Peters, D. I. Graham, J. Patterson, A. F. Dominiczak, and I. M. Macrae Characterization of the Microglial Response to Cerebral Ischemia in the Stroke-Prone Spontaneously Hypertensive Rat Hypertension, July 1, 2001; 38(1): 116 - 122. [Abstract] [Full Text] [PDF]
|
|